The COVID-19 pandemic is affecting all of us around the world. Abbott is putting its resources towards helping you navigate this crisis. As a leader in diagnostic testing, we have a unique responsibility to contribute our expertise to help fight the COVID-19 pandemic.
To help provide the critical diagnostic information needed, Abbott is currently providing, and continuing to develop, tests across its diagnostic platforms.
We thank you for your patience and understanding as we do our part to manufacture products that help keep communities safe.
The ID NOW™ COVID-19 assay is now available for use on the ID NOW platform under U.S. Food and Drug Administration Emergency Use Authorization (EUA). The ID NOW™ COVID-19 rapid test delivers high-quality molecular positive results in as little as 5 minutes, targeting the coronavirus (COVID-19) RdRp Gene.
Based on your current location, the content on this page may not be relevant for your country.
